Article
Human genetics as a model for target validation: finding new therapies for diabetes.
Diabetologia - 1 Jun 2017
Thomsen Soren K, Gloyn Anna L
Abstract excerpt
Type 2 diabetes is a global epidemic with major effects on healthcare expenditure and quality of life. Currently available treatments are inadequate for the prevention of comorbidities, yet progress towards new therapies remains slow. A major barrier is the insufficiency of traditional preclinical models for predicting drug efficacy and safety. Human genetics offers a complementary model to assess causal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
